Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Other Operating Expenses (2024 - 2025)

CervoMed (CRVO) has disclosed Other Operating Expenses for 7 consecutive years, with -$177518.0 as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 56.71% to -$177518.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$288490.0 through Dec 2025, down 55.81% year-over-year, with the annual reading at -$610561.0 for FY2025, 93.9% down from the prior year.
  • Other Operating Expenses hit -$177518.0 in Q4 2025 for CervoMed, down from -$110972.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of -$71878.0 in Q3 2024 to a low of -$177518.0 in Q4 2025.